Empiricotx
1 known investors
Empirico discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that have beneficial effects on health and disease. Using its human genetics and siRNA chemistry platforms, the company advances a pipeline of clinical and preclinical precision medicine programs targeting common diseases with unmet need.
Investors · 1
Frequently asked questions
- What does Empiricotx do?
- Empirico discovers and develops siRNA medicines designed to mimic naturally-occurring genetic variants that have beneficial effects on health and disease. Using its human genetics and siRNA chemistry platforms, the company advances a pipeline of clinical and preclinical precision medicine programs targeting common diseases with unmet need.
- Who are Empiricotx's investors?
- Empiricotx's investors include Neotribe Ventures.